Cardiopharma, Inc.

The CardiaPill® is a patented platform technology and includes three of the most commonly prescribed CVD medications (US$40BN sales p/a):

  1. Cholesterol lowering agent ("statin")
  2. Antihypertensive agent ("ACE inhibitor")
  3. Anti-platelet drug (aspirin)

All in a single, easy to swallow capsule.

The Product is characterized by having:


Due to Zoticon's regulatory expertise, Cardiopharma is able to utilize a novel regulatory pathway to market. Estimated NDA filing: 2014.